Online Program

287211
Prenatal exposures to bisphenol a (BPA) in 10 Caribbean countries


Wednesday, November 6, 2013 : 9:30 a.m. - 9:50 a.m.

Martin Forde, Professor, Department of Public Health and Preventive Medicine, St. George's University, St. George's, Grenada
There is a growing body of evidence that exposures to bisphenol A (BPA) can lead to adverse health outcome. In this study, the prevalence of BPA was assessed in 10 Caribbean countries by taking maternal urine samples from approximately 50 pregnant women in each island. BPA was detected in all samples ranging from a low geometric mean of 1.46 μg/L (Antigua & Barbuda) to a high of 4.88 μg/L (St. Kitts & Nevis). These data were then compared with comparable data from Canada and the U.S. All sampled Caribbean islands had geometric mean concentration levels that were higher than those recorded in Canada (1.26 μg/L); four Caribbean islands had geometric mean concrentation levels that were higher than those recorded in the U.S. (2.41 μg/L). While the full impact on human health from low level exposures to BPA are still being fully evaluated, this first systematic biomonitoring study on the concentrations of BPA in maternal samples taken from 10 Caribbean countries clearly points to the need for Caribbean governments and public health officials to have programs in place that continuously monitor, intervene, and evaluate these exposures in Caribbean persons to ensure that they are reduced as far as possible.

Learning Areas:

Advocacy for health and health education
Basic medical science applied in public health
Conduct evaluation related to programs, research, and other areas of practice
Public health or related public policy
Public health or related research

Learning Objectives:
Evaluate the magnitude of bisphenol A (BPA) exposures experienced by pregnant women living in 10 Caribbean countries. Identify intervention efforts to those Caribbean islands that have the highest exposure rates. List and review the potential health effects of low level exposures to BPA especially on developing fetuses and neonates.

Keyword(s): Children's Health, Prenatal Care

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I was one of two co-principal investigators on the grant that facilitated and executed the research that produced the results I wish to present at this conference. Besides looking at BPA exposures, I have been involved in evaluating exposures to several other toxicants such as persistent organic pollutants (POPs), lead, mercury, and pesticides.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.